Nicklaus Children’s Hospital Is First in Region to Offer Sedation-Free Evaluation of Upper Gastrointestinal Tract in Children

Key Takeaways

• First South Florida hospital offering sedation‑free transnasal pediatric endoscopy
• Reduces need for anesthesia, IV lines, and fasting for children
• Benefits children with eosinophilic esophagitis requiring multiple procedures
• Enables outpatient office procedures, minimizing school and work disruptions
• EvoEndo’s single‑use system expands pediatric gastroenterology options

Pulse Analysis

Transnasal endoscopy, a minimally invasive technique that accesses the upper digestive tract through the nose, is gaining traction as a sedation‑free alternative to traditional oral endoscopy. EvoEndo’s single‑use gastroscope, designed for children as young as five, eliminates the need for general anesthesia, intravenous access, and lengthy recovery periods. By allowing the procedure to be performed in an outpatient setting, hospitals can streamline scheduling, reduce overhead costs, and enhance the overall patient experience. This shift aligns with broader healthcare trends favoring less invasive, cost‑effective diagnostics.

For pediatric gastroenterology, the impact is particularly pronounced. Children with eosinophilic esophagitis often require serial endoscopic evaluations to monitor disease progression and treatment response. Sedation‑free TNE reduces the cumulative exposure to anesthesia, a concern for developing brains, while also minimizing missed school days and parental work absences. The ability to conduct the exam without extensive fasting further eases the logistical burden on families. Clinicians at Nicklaus Children’s Hospital report smoother workflow and higher satisfaction rates, suggesting that TNE could become the preferred modality for routine upper GI assessments in children.

Industry observers see EvoEndo’s partnership with Nicklaus Children’s as a bellwether for wider adoption of pediatric‑focused, single‑use endoscopic devices. As reimbursement models increasingly reward value‑based care, hospitals that can deliver safe, efficient diagnostics without sedation stand to gain a competitive edge. The technology also mitigates infection risk associated with reusable scopes, an advantage highlighted during the recent pandemic. If other regional centers follow suit, the market could see accelerated growth in pediatric endoscopy platforms, prompting further innovation and potentially expanding the indication set beyond gastroenterology to otolaryngology and pulmonology.